Renaissance Technologies - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$381,000
-85.7%
26,000
-86.2%
0.00%
-100.0%
Q3 2020$2,673,000
-6.9%
188,257
-47.0%
0.00%
+50.0%
Q2 2020$2,870,000
+326.4%
355,321
+206.0%
0.00%
+100.0%
Q3 2018$673,000
-42.2%
116,100
-37.5%
0.00%0.0%
Q2 2018$1,164,000
+288.0%
185,700
+345.3%
0.00%
Q1 2018$300,000
-73.6%
41,700
-73.4%
0.00%
-100.0%
Q4 2017$1,138,000
+382.2%
157,022
+516.3%
0.00%
Q1 2016$236,000
-22.4%
25,478
+5.7%
0.00%
-100.0%
Q4 2015$304,00024,0980.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders